Panax ginseng ginsenoside-Rg₂ protects memory impairment via anti-apoptosis in a rat model with vascular dementia

Ethnopharmacological relevance: Ginsenosides, the major active ingredients of Panax ginseng, produce a variety of pharmacological or physiological responses with effects on the central and peripheral nervous systems. Aim of the Study: In this report, we investigated the effects of ginsenoside Rg₂ on...

Full description

Saved in:
Bibliographic Details
Published inJournal of ethnopharmacology Vol. 115; no. 3; pp. 441 - 448
Main Authors Zhang, Guizhi, Liu, Ailing, Zhou, Yingbin, San, Xun, Jin, Taowei, Jin, Yi
Format Journal Article
LanguageEnglish
Published Shannon Amsterdam; New York: Elsevier 12.02.2008
Elsevier
Subjects
Rat
Online AccessGet full text
ISSN0378-8741
1872-7573
DOI10.1016/j.jep.2007.10.026

Cover

More Information
Summary:Ethnopharmacological relevance: Ginsenosides, the major active ingredients of Panax ginseng, produce a variety of pharmacological or physiological responses with effects on the central and peripheral nervous systems. Aim of the Study: In this report, we investigated the effects of ginsenoside Rg₂ on cerebral ischemia-reperfusion induced impairment of neurological responses, memory and caudate-putamen neuronal apoptosis in a vascular dementia (VD) rat model. Materials and Methods: Neurological evaluation was performed 24h after reperfusion and Y-maze memory performance was assessed at 48h after reperfusion. Immunocytochemical techniques were employed to check the protein expression of BCL-2, BAX, heat shock protein 70 and P53, which are related with cell apoptosis. Results: Neurological responses and memory ability of the ginsenoside Rg₂ or nimodipine groups improved significantly compared with the VD group. The expression of BCL-2 and HSP70 were decreased, while BAX and P53 were increased in the VD model. The expression of BCL-2 and HSP70 proteins were increased, while BAX and P53 decreased after ginsenoside Rg₂ (2.5, 5 and 10mg/kg) and nimodipine (50μg/kg) treatment compared with the VD group. The study suggests that ginsenoside Rg₂ improved neurological performance and memory ability of VD rats through mechanisms related to anti-apoptosis. Conclusions: The capacity for ginsenoside Rg₂ to modulate the expression of apoptotic related proteins suggests that ginsenoside Rg₂ may represent a potential treatment strategy for vascular dementia or other ischemic insults.
Bibliography:http://dx.doi.org/10.1016/j.jep.2007.10.026
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0378-8741
1872-7573
DOI:10.1016/j.jep.2007.10.026